Molecular Imaging: Page 448

Dilon, Naviscan settle patent dispute

By AuntMinnie.com staff writers

Scintimammography developer Dilon Technologies of Newport News, VA, and PET developer Naviscan PET Systems of San Diego have buried the hatchet in a dispute over patent technologies.

December 20, 2007

Study shows benefits of very delayed cerebral FDG-PET imaging

By Wayne Forrest

Acquisition of PET images as long as six hours after FDG injection can be a useful and easy-to-perform technique in delineating gliomas from gray matter and detecting cerebral lymphomas, according to a study by researchers in France. They presented their findings at the recent 2007 RSNA meeting in Chicago.

December 20, 2007

Neoprobe extends agreement with Ethicon

By AuntMinnie.com staff writers

Gamma camera probe developer Neoprobe of Dublin, OH, has extended its marketing and distribution agreement with Ethicon Endo-Surgery of Cincinnati.

December 19, 2007

BioSphere nets CE Mark OK

By AuntMinnie.com staff writers

Interventional device developer BioSphere Medical has received the European CE Mark for transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) using its HepaSphere microspheres.

December 17, 2007

Bristol-Myers Squibb finds buyer for imaging unit

By AuntMinnie.com staff writers

Pharmaceutical developer Bristol-Myers Squibb of New York City has inked a deal to sell its medical imaging unit to a private equity firm for $525 million. The deal will include the division's portfolio of contrast products, including its popular Cardiolite radiopharmaceutical for cardiac SPECT imaging.

December 16, 2007

MDS expects less impact from reactor shutdown

By AuntMinnie.com staff writers

MDS, parent company to radioisotope developer MDS Nordion of Kanata, Ontario, said the temporary shutdown of the Chalk River nuclear reactor will have less of a financial impact on the company than anticipated.

December 16, 2007